Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone Treatment in Heart Failure with Reduced Ejection Fraction
NCT07134972Completed
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Open-label trial of medical ozonated water in heart failure with reduced ejection fraction (HFrEF) (2 arms). Primary endpoint: Number of patients who had acute heart failure at 2 months. Started Jan 2024; status: completed.
02
Drugs
medical ozonated water
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT07134972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07134972.